- New Ph. Eur. reference standards and Replacement batches for Ph. Eur. reference standards
- Distribution quota
- Removal
- Future removal
- Change of sales units
- Information on change of amount per unit
- Information on change of price
- Change of EDQM storage/shipping conditions
- Information on International Chemical Reference Substances (ICRS) and International Standards for Antibiotics (ISA)
- Rules about Substances depleting the ozone layer
See also:
- Content of the Ph. Eur. RS catalogue
- How to place an RS order
- The EDQM helps the users to test some draft texts proposed in Pharmeuropa through Qualified Samples
The European Directorate for the Quality of Medicines & HealthCare (EDQM) announces the release of:
5 new European Pharmacopoeia (Ph. Eur.) reference standards:
Catalogue code |
Name |
Batch |
Unit quantity |
Price |
Chloroxylenol CRS |
1 |
160 mg |
79 EUR |
|
Etravirine CRS |
1 |
220 mg |
300 EUR |
|
Etravirine for peak identification |
1 |
10 mg |
300 EUR |
|
Etravirine for system suitability |
1 |
10 mg |
300 EUR |
|
Bromperidol for system suitability CRS |
1 |
0.74 mg |
79 EUR |
20 replacement batches for Ph. Eur. reference standards:
Catalogue code |
Name |
Batch |
Unit quantity |
Price |
Clotrimazole for peak identification CRS |
4 |
1.005 mg |
79 EUR |
|
Nimesulide CRS |
3 |
100 mg |
79 EUR |
|
Salbutamol impurity B CRS |
9 |
5 mg |
79 EUR |
|
Amlodipine for peak identification CRS |
5 |
10 mg |
79 EUR |
|
Vanillin CRS |
3 |
100 mg |
79 EUR |
|
Ethyl indole-3-carboxylate CRS |
2 |
15 mg |
79 EUR |
|
Sertraline impurity E CRS |
2 |
20 mg |
79 EUR |
|
Erythromycin C CRS |
8 |
25 mg |
79 EUR |
|
Norfloxacin for system suitability CRS |
6 |
10 mg |
79 EUR |
|
Sumatriptan impurity mixture CRS |
10 |
3 mg |
79 EUR |
|
Rosuvastatin for peak identification CRS |
5 |
15 mg |
79 EUR |
|
Aspartame CRS |
3 |
40 mg |
79 EUR |
|
Oseltamivir impurity A CRS |
3 |
10 mg |
79 EUR |
|
Sodium hyaluronate BRP |
4 |
300 mg |
79 EUR |
|
Ceftriaxone impurity A CRS |
7 |
10 mg |
79 EUR |
|
Promethazine hydrochloride CRS |
3 |
50 mg |
79 EUR |
|
Ciprofibrate for system suitability A CRS |
2 |
5.03 mg |
79 EUR |
|
Levonorgestrel for system suitability 2 CRS |
2 |
10 mg |
79 EUR |
|
Cannabidiol impurity J |
2 |
0.006 mg |
150 EUR |
|
Nitrofural for peak identification A CRS |
2 |
0.105 mg |
79 EUR |
Distribution quota
Information on distribution quota for Immunoglobulin (anti-A, anti-B antibodies test Negative control) BRP (Y0001689)
Due to premature depletion of stocks of the Immunoglobulin (anti-A, anti-B antibodies test Negative control) BRP (cat. # Y0001689), we wish to inform users that a tight distribution quota has been established.
This BRP will be distributed to plasma-derived therapeutic product manufacturers and Official Medicines Control Laboratories only, with a maximum of 1 unit per month. This quota may be adjusted according to availability.
This exceptional measure will remain in place until the next batch of this BRP is established, which is expected by the end of 2024.
Distribution of the Immunoglobulin for anti-A, anti-B antibodies limit test BRP (cat. # Y0001153) and the Immunoglobulin (anti-A, anti-B antibodies test Positive control) BRP (cat. # Y0001688) is not affected by this measure.
We apologise for any inconvenience caused and thank you for your understanding.
Information on reference standards removed from catalogue
Supplement 11.3
Following the implementation of Supplement 11.3, the following standards are officially withdrawn (or replaced) from 1 January 2024.
Y0002166 |
Donepezil Hydrochloride Monohydrate |
These standards will nevertheless remain available for sale, subject to sufficient stock, until 1 July 2024. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1 January 2025) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details. |
Y0000679 |
Mepyramine impurity A |
|
Y0001288 |
Salbutamol sulfate for system suitability (replaced by Salbutamol for peak identification CRS Y0002386) |
|
Y0000030 |
Salbutamol impurity B |
|
Y0000071 |
Salbutamol impurity D |
|
Y0000031 |
Salbutamol impurity F |
|
Y0000034 |
Salbutamol impurity G |
|
Y0000032 |
Salbutamol impurity I |
|
Y0000371 |
Sestamibi labelling kit (replaced by Sestamibi labelling kit A CRS Y0002420) |
|
Y0000115 |
Sotalol impurity B |
|
T2200010 |
Trimethoprim impurity B |
|
Y0000684 |
Trimethoprim for system suitability (replaced by Trimethoprim for peak identification CRS Y0002392) |
Information on reference standards with a future removal from catalogue
Additional removal from catalogue
Catalogue code |
Name |
|
---|---|---|
I0305000 |
Insulin (bovine) CRS |
This reference standard will be officially withdrawn from sale on 30/06/2024. The reference will remain visible in the catalogue until 31/12/2024. |
Supplement 11.4
Following the implementation of Supplement 11.4, the following standards will be officially withdrawn (or replaced) from 1st April 2024.
S2400004 |
Suxibuzone impurity B CRS |
These standards will nevertheless remain available for sale, subject to sufficient stock, until 1st October 2024. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1st April 2025) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details. |
T0040000 |
Temazepam CRS - * psy |
|
Y0000346 |
Temazepam impurity F CRS |
|
Y0000344 |
Temazepam impurity C CRS |
|
Y0000345 |
Temazepam impurity D CRS |
|
Y0000347 |
Temazepam impurity G CRS |
|
Y0002071 |
Calcium folinate for system suitability CRS (replaced by calcium folinate for system suitability A CRS) |
Supplement 11.5
Following the implementation of Supplement 11.5, the following standard will be officially withdrawn (or replaced) from 1st July 2024.
C2320000 |
Clomifene citrate CRS |
These standards will nevertheless remain available for sale, subject to sufficient stock, until 1st January 2025. Likewise, they will remain in the catalogue for a period of 12 months (i.e. until 1st July 2025) to allow users to print the batch validity statement (BVS). See “Change in the policy for withdrawing reference standards from sale” for more details. |
Change of sales units
- None
Information on change of amount per unit
- Nitrofural for peak identification A CRS (Y0002295) batch 2 contains 0.105 mg per unit (0.110 mg previously)
- Ciprofibrate for system suitability A CRS (Y0002327) batch 2 contains 5.03 mg per unit (5.00 mg previously)
- Ethyl indole-3-carboxylate CRS (Y0000617) batch 2 contains 15 mg per unit (10 mg previously)
- Sertraline impurity E CRS (Y0001285) batch 2 contains 20 mg per unit (15 mg previously)
Information on change of price
- None
Information on change of EDQM storage/shipping conditions
Based on new stability information, storage and shipping conditions has been changed on 15 April 2024 for the following reference standard:
- Rosuvastatin impurity mixture (Y0002167) CRS batch 2 is stored at -20°C (previously +5°C) and shipped on ice at -20°C (previously ambiant).
Information on International Chemical Reference Substances (ICRS) and International Standards for Antibiotics (ISA)
ICRS
- None
ISA
- None
Rules about Substances depleting the ozone layer
Regulation (EU) 2024/590 on substances that deplete the ozone layer entered into force on 11 March 2024. The rules governing the placing on the market and use of ozone-depleting substances for essential laboratory and analytical uses have now changed.
Under the new regulation, standards shipped to a location within the European Union no longer need to be registered in the labODS registry.
There is no change to the procedure for shipments outside the European Union.
The EDQM Reference Standards affected by this change are:
Class 1 residual solvent solution CRS |
|
Trichlorotrifluoroethane CRS |
Important notes:
In all cases, these Reference Standards supplied by the EDQM must be used exclusively for essential laboratory and analytical uses (i.e. for analytical uses in conjunction with the texts published in the European Pharmacopoeia).
We would also like to draw your attention to the obligations of users affected by this change that are described under Article 8(4) of this regulation.
Content of the European Pharmacopoeia RS catalogue
The EDQM proposes more than 3 100 Ph. Eur. RS including a wide range of highly characterised chemical reference substances (CRS), herbal reference standards (HRS) and biological reference preparations (BRP), as well as reference spectra for the tests and assays to be carried out in accordance with the official methods prescribed in the Ph. Eur.
The Ph. Eur. RS catalogue is updated on a daily basis and gives access not only to all the Ph. Eur. RS, but also to:
- batch validity statements (BVSs) for each reference standard;
- Safety Data Sheets and Safety Data Statements for hazardous biologicals;
- leaflets (downloadable PDFs).
For your convenience, the Ph. Eur. RS catalogue is published daily and can be downloaded in in PDF format and in XML format.
When stocks of a given reference standard are low, the EDQM reserves the right to limit the quantities sold to each user to ensure that as many users as possible will receive at least some of the quantities available. Restrictions on quantities are applied at the time the purchase order is received.
Following a request from many users, the quantities allowed in case of sales restrictions now appear in the online catalogue as well as in the catalogue in XML format.
The EDQM is also responsible for the establishment, preparation, storage and distribution of WHO International Chemical Reference Standards (ICRS) and International Standards for Antibiotics (ISA).
How to place an RS order
If you wish to place an order, you can send your request to the EDQM either:
- via the WebStore;
- or by e-mail to [email protected] (in this case, please ensure that your order, on your company letterhead, states both the catalogue code and substance name and is attached to your e-mail).
A video has been prepared to help user ordering through the RS WebStore.
The EDQM helps the users to test some draft texts proposed in Pharmeuropa through Qualified Samples
In some cases, ‘qualified samples’ are made available by the EDQM at the time of publication in Pharmeuropa to allow users to check the changes (e.g. to the related substances test) proposed during the public enquiry and best prepare for the implementation of the monograph.
Where a qualified sample is available, it is described in the briefing note of the Pharmeuropa monograph and may be ordered free of charge by raising a request in the EDQM HelpDesk.
After use, users are kindly requested to share their results with the EDQM.
To place an order via the EDQM HelpDesk, please click on European Pharmacopoeia and choose the category Question about General Chapters and Monographs. Providing us with your full shipping address and the title of the corresponding Ph. Eur. monograph, while stating ‘Qualified sample’ in the subject of the query, will help us to rapidly process your request.
For further information on how to use the EDQM HelpDesk, please see the HelpDesk User Manual.